Scientists use gene therapy to cure immune deficient child

BMJ 2002; 325 doi: 10.1136/bmj.325.7354.10 (Published 6 July 2002)
Cite this as: BMJ 2002;325:10.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Judy Siegel-Itzkovich
  1. Jerusalem

    An international team of scientists has managed to cure a child with severe combined immunodeficiency (SCID) using gene therapy.

    Patients with SCID are usually treated by replacing an essential enzyme, adenosine deaminase, which is lacking in such people. But this treatment is effective for only a couple of days at a time and is expensive. Some patients can have a bone marrow transplant, but only if a good match can be found.

    The team was headed by Professor Shimon Slavin, of the Hadassah University Hospital in Jerusalem, and his colleagues Dr Shoshana Morecki and Dr Memet Aker. They collaborated with Dr Allesandro Aiuti and other staff from the San Raffaele Institute for …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL